Autoregulation: mediators and renin–angiotensin system in diseases and treatments
Abstract Background Hemodynamic regulation is a substantial part of the physiological integrity of the human body. It is based on the delivery of proper blood perfusion to every organ. Five primary vasoactive substances are nearly located throughout the human body, either released from the endotheli...
Main Author: | Antony Sameh Mansour |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-04-01
|
Series: | Future Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43094-023-00482-4 |
Similar Items
-
Reply to Siniorakis et al., “COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure”
by: David S. Fedson, et al.
Published: (2020-06-01) -
Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats
by: Shao-Jung Hsu, et al.
Published: (2020-04-01) -
Impact of the angiotensin receptor‐neprilysin inhibitor in clinical diabetes management: Potential benefits and pitfalls
by: Tomoko Kato, et al.
Published: (2023-09-01) -
Renin-Angiotensin System: A Review of Historical Perspectives
by: Olga Kovalyova, et al.
Published: (2023-05-01) -
Correlation between plasma-soluble angiotensin-converting enzyme 2, anti- angiotensin-converting enzyme 2, and angiotensin-(1–7) in patients with chronic heart failure
by: Yi Gu, et al.
Published: (2019-01-01)